Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment
Source: Article title. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Publisher article type: review-article
Source: Publisher publication metadata.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment
Review / evidence synthesis · Cancers · 2025
Original publication title
The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment
© 2025 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Simple Summary
Breast cancer (BC) develops within a complex tumor microenvironment (TME) consisting of cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix, all of which play a crucial role in tumor progression and metastasis. Vitamin D (VD) is widely recognized for its protective effects against BC, due to its ability to regulate the cell cycle, promote apoptosis, inhibit angiogenesis, and suppress metastasis. While the anti-cancer properties of VD have been extensively studied, its specific role within the BC TME remains underexplored.
This review highlights VD’s regulatory influence on various TME components, underscoring its potential to reshape the TME and enhance BC treatment strategies.
Abstract
The intricate and diverse TME within breast cancer (BC) comprises a complex amalgamation of cell populations, encompassing immune cells, cancer-associated fibroblasts, cancer stem cells and the extracellular matrix. These constituents have profound influence over tumor progression and metastasis. Vitamin D (VD) is increasingly recognized as a multifunctional hormone, with strong clinical and epidemiological evidence supporting its protective role against cancer, particularly BC. Although its anti-neoplastic effects in BC have been widely studied, few investigations have thoroughly explored its influence within the tumor microenvironment (TME).
This review seeks to address that gap by clarifying the current understanding of VD’s regulatory functions in the TME of BC. The pivotal anti-cancer functions of VD comprise a spectrum of activities, influencing cell cycle regulation, chemoprotection, differentiation, apoptosis, proliferation, angiogenesis, as well as having anti-metastatic and anti-invasive properties. In this review, we comprehensively outline VD’s anti-cancer mechanisms within the context of the BC TME, meticulously detailing its regulatory impact on cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix.
This unique perspective highlights the potential of using VD to re-program the TME and enhance the efficacy of current BC therapeutics.
Authors’ abstract
Simple Summary
Breast cancer (BC) develops within a complex tumor microenvironment (TME) consisting of cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix, all of which play a crucial role in tumor progression and metastasis. Vitamin D (VD) is widely recognized for its protective effects against BC, due to its ability to regulate the cell cycle, promote apoptosis, inhibit angiogenesis, and suppress metastasis. While the anti-cancer properties of VD have been extensively studied, its specific role within the BC TME remains underexplored.
This review highlights VD’s regulatory influence on various TME components, underscoring its potential to reshape the TME and enhance BC treatment strategies.
Abstract
The intricate and diverse TME within breast cancer (BC) comprises a complex amalgamation of cell populations, encompassing immune cells, cancer-associated fibroblasts, cancer stem cells and the extracellular matrix. These constituents have profound influence over tumor progression and metastasis. Vitamin D (VD) is increasingly recognized as a multifunctional hormone, with strong clinical and epidemiological evidence supporting its protective role against cancer, particularly BC. Although its anti-neoplastic effects in BC have been widely studied, few investigations have thoroughly explored its influence within the tumor microenvironment (TME).
This review seeks to address that gap by clarifying the current understanding of VD’s regulatory functions in the TME of BC. The pivotal anti-cancer functions of VD comprise a spectrum of activities, influencing cell cycle regulation, chemoprotection, differentiation, apoptosis, proliferation, angiogenesis, as well as having anti-metastatic and anti-invasive properties. In this review, we comprehensively outline VD’s anti-cancer mechanisms within the context of the BC TME, meticulously detailing its regulatory impact on cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix.
This unique perspective highlights the potential of using VD to re-program the TME and enhance the efficacy of current BC therapeutics.
Publication and source details
Original title: The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment
Balquees Kanwal; Syeda Saba Shah; Farzana Shaheen; Mekonnen Sisay Shiferaw; Deepanshu Maurya; Yujie Li; Saranya Pounraj; Zaklina Kovacevic
Cancers · 2025
* Correspondence: z.kovacevic@unsw.edu.au© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:27:04.476897+00:00
DOI: 10.3390/cancers17233751 · PMC12691352